Beximco Pharmaceuticals (FRA:R2WA) Receivables Turnover : 3.07 (As of Dec. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Beximco Pharmaceuticals Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Beximco Pharmaceuticals's Revenue for the three months ended in Dec. 2024 was €93.6 Mil. Beximco Pharmaceuticals's average Accounts Receivable for the three months ended in Dec. 2024 was €30.5 Mil. Hence, Beximco Pharmaceuticals's Receivables Turnover for the three months ended in Dec. 2024 was 3.07.

Beximco Pharmaceuticals Receivables Turnover Historical Data

The historical data trend for Beximco Pharmaceuticals's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beximco Pharmaceuticals Receivables Turnover Chart

Beximco Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Receivables Turnover

Get a 7-Day Free Trial

7.97

10.15

12.19

12.40

12.99

Beximco Pharmaceuticals Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Receivables Turnover	Get a 7-Day Free Trial															2.94	2.94	3.14	3.15	3.07

Competitive Comparison of Beximco Pharmaceuticals's Receivables Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Beximco Pharmaceuticals's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beximco Pharmaceuticals's Receivables Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beximco Pharmaceuticals's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Beximco Pharmaceuticals's Receivables Turnover falls into.

Save Embed

;

Save Embed

;

Beximco Pharmaceuticals Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Beximco Pharmaceuticals's Receivables Turnover for the fiscal year that ended in Jun. 2024 is calculated as

	Receivables Turnover (A: Jun. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Jun. 2024 )	/ (	(Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Jun. 2024 ))	/	count )
=	337.895	/ (	(25.651	+	26.354)	/	2 )
=	337.895	/	26.0025
=	12.99

Beximco Pharmaceuticals's Receivables Turnover for the quarter that ended in Dec. 2024 is calculated as

	Receivables Turnover (Q: Dec. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Dec. 2024 )	/ (	(Accounts Receivable (Q: Sep. 2024 )	+	Accounts Receivable (Q: Dec. 2024 ))	/	count )
=	93.62	/ (	(30.171	+	30.802)	/	2 )
=	93.62	/	30.4865
=	3.07

Beximco Pharmaceuticals (FRA:R2WA) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Beximco Pharmaceuticals Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Beximco Pharmaceuticals's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Beximco Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beximco Pharmaceuticals Ltd (FRA:R2WA) » Definitions » Receivables Turnover

Traded in Other Exchanges

BXP:UK BXPHARMA:Bangladesh

Address

19 Dhanmondi, Road No. 7, Dhaka, BGD, 1205

Website

https://www.beximcopharma.com

Beximco Pharmaceuticals Ltd is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from domestic sales.

Beximco Pharmaceuticals Headlines

No Headlines